Best Practice & Research Clinical Gastroenterology最新文献_第6页

Curative criteria for endoscopic treatment of oesophageal adenocarcinoma 食管腺癌内窥镜治疗的治愈标准

IF 3.2 3区医学

Best Practice & Research Clinical Gastroenterology Pub Date : 2024-02-01 DOI: 10.1016/j.bpg.2024.101886

Annemijn D.I. Maan , Prateek Sharma , Arjun D. Koch

引用次数: 0

Endoscopic resection for residual oesophageal neoplasia after definitive chemoradiotherapy 内镜下切除最终化疗后残留的食道肿瘤

IF 3.2 3区医学

Best Practice & Research Clinical Gastroenterology Pub Date : 2024-02-01 DOI: 10.1016/j.bpg.2024.101885

Judith Honing, Arjun D. Koch, Peter D. Siersema, Manon Spaander

引用次数: 0

Multimodal cancer treatment with endoscopy 利用内窥镜进行多模式癌症治疗

IF 3.2 3区医学

Best Practice & Research Clinical Gastroenterology Pub Date : 2024-02-01 DOI: 10.1016/j.bpg.2024.101892

Michal F. Kaminski, Nastazja Dagny Pilonis

引用次数: 0

Models and scores to predict adequacy of bowel preparation before colonoscopy 预测结肠镜检查前肠道准备是否充分的模型和分数

IF 3.2 3区医学

Best Practice & Research Clinical Gastroenterology Pub Date : 2023-12-01 DOI: 10.1016/j.bpg.2023.101859

Romane Fostier , Georgios Tziatzios , Antonio Facciorusso , Apostolis Papaefthymiou , Marianna Arvanitakis , Konstantinos Triantafyllou , Paraskevas Gkolfakis

{"title":"Models and scores to predict adequacy of bowel preparation before colonoscopy","authors":"Romane Fostier , Georgios Tziatzios , Antonio Facciorusso , Apostolis Papaefthymiou , Marianna Arvanitakis , Konstantinos Triantafyllou , Paraskevas Gkolfakis","doi":"10.1016/j.bpg.2023.101859","DOIUrl":"10.1016/j.bpg.2023.101859","url":null,"abstract":"<div><p><span><span><span>Adequate bowel preparation is of paramount importance for the effectiveness of preventive </span>colonoscopy as it allows visualization of the </span>mucosal surface and </span>adenomas<span> detection, the pre-malignant lesions leading to colon cancer. Still, a considerable portion of patients fail to achieve adequate bowel cleansing, with predictors of inadequate bowel preparation being at the focal point of several studies, so far. Incorporation of these factors within predictive models has been implemented in an effort to promptly identify patients at risk for inadequate bowel preparation and thus, timely adopt practices that have the potential to improve bowel cleansing. Ultimately, this could lead to improved procedural outcomes not only in terms of neoplastic detection rate but also interval repeat procedures, expenses, patient convenience and adverse events risk. Aim of this manuscript is to present an up to date overview of all predictive scores/models addressing bowel cleansing adequacy in everyday clinical practice.</span></p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79929001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Predictive models in EUS/ERCP EUS/ERCP 的预测模型

IF 3.2 3区医学

Best Practice & Research Clinical Gastroenterology Pub Date : 2023-12-01 DOI: 10.1016/j.bpg.2023.101856

Barbara Lattanzi , Daryl Ramai , Paraskevas Gkolfakis , Antonio Facciorusso

{"title":"Predictive models in EUS/ERCP","authors":"Barbara Lattanzi , Daryl Ramai , Paraskevas Gkolfakis , Antonio Facciorusso","doi":"10.1016/j.bpg.2023.101856","DOIUrl":"10.1016/j.bpg.2023.101856","url":null,"abstract":"<div><p>Predictive models (PMs) in endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) have the potential to improve patient outcomes, enhance diagnostic accuracy, and guide therapeutic interventions. This review aims to summarize the current state of predictive models in ERCP and EUS and their clinical implications. To be considered useful in clinical practice a PM should be accurate, easy to perform, and may consider objective variables. PMs in ERCP estimate correct indication, probability of success, and the risk of developing adverse events. These models incorporate patient-related factors and technical aspects of the procedure. In the field of EUS, these models utilize clinical and imaging data to predict the likelihood of malignancy, presence of specific lesions, or risk of complications related to therapeutic interventions. Further research, validation, and refinement are necessary to maximize the utility and impact of these models in routine clinical practice.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1521691823000367/pdfft?md5=cbc3471b10ee516e7622904aa3da3a59&pid=1-s2.0-S1521691823000367-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88082400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prognostic models in end stage liver disease 肝病晚期的预后模型

IF 3.2 3区医学

Best Practice & Research Clinical Gastroenterology Pub Date : 2023-12-01 DOI: 10.1016/j.bpg.2023.101866

A. Ferrarese, M. Bucci, A. Zanetto, M. Senzolo, G. Germani, M. Gambato, F.P. Russo, P. Burra

{"title":"Prognostic models in end stage liver disease","authors":"A. Ferrarese, M. Bucci, A. Zanetto, M. Senzolo, G. Germani, M. Gambato, F.P. Russo, P. Burra","doi":"10.1016/j.bpg.2023.101866","DOIUrl":"10.1016/j.bpg.2023.101866","url":null,"abstract":"<div><p><span>Cirrhosis is a major cause of death worldwide, and is associated with significant health care costs. Even if milestones have been recently reached in understanding and managing end-stage liver disease (ESLD), the disease course remains somewhat difficult to prognosticate. These difficulties have already been acknowledged already in the past, when scores instead of single parameters have been proposed as valuable tools for short-term prognosis. These standard scores, like Child Turcotte Pugh (CTP) and model for end-stage liver disease (MELD) score, relying on biochemical and clinical parameters, are still widely used in clinical practice to predict short- and medium-term prognosis. The MELD score, which remains an accurate, easy-to-use, objective predictive score, has received significant modifications over time, in order to improve its performance especially in the </span>liver transplant (LT) setting, where it is widely used as prioritization tool. Although many attempts to improve prognostic accuracy have failed because of lack of replicability or poor benefit with the comparator (often the MELD score or its variants), few scores have been recently proposed and validated especially for subgroups of patients with ESLD, as those with acute-on-chronic liver failure. Artificial intelligence will probably help hepatologists in the near future to fill the current gaps in predicting disease course and long-term prognosis of such patients.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77089742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Scoring systems for risk stratification in upper and lower gastrointestinal bleeding 上下消化道出血风险分层评分系统

IF 3.2 3区医学

Best Practice & Research Clinical Gastroenterology Pub Date : 2023-12-01 DOI: 10.1016/j.bpg.2023.101871

Franco Radaelli , Simone Rocchetto , Alessandra Piagnani , Alberto Savino , Dhanai Di Paolo , Giulia Scardino , Silvia Paggi , Emanuele Rondonotti

{"title":"Scoring systems for risk stratification in upper and lower gastrointestinal bleeding","authors":"Franco Radaelli , Simone Rocchetto , Alessandra Piagnani , Alberto Savino , Dhanai Di Paolo , Giulia Scardino , Silvia Paggi , Emanuele Rondonotti","doi":"10.1016/j.bpg.2023.101871","DOIUrl":"10.1016/j.bpg.2023.101871","url":null,"abstract":"<div><p>Several scoring systems have been developed for both upper and lower GI bleeding to predict the bleeding severity and discriminate between low-risk patients, who may be suitable for outpatient management, and those who would likely need hospital-based interventions and are at high risk for adverse outcomes. Risk scores created to identify low-risk patients (namely the Glasgow Blatchford Score and the Oakland score) showed very good discriminative performances and their implementation has proven to be effective in reducing hospital admissions and healthcare burden. Conversely, the performances of risk scores in identifying specific adverse events to define high-risk patients are less accurate, and whether their integration into routine clinical practice has a tangible impact on patient management remains unproven.</p><p>This review describes the existing risk score systems for GI bleeding, emphasizes key research findings, elucidates the circumstances in which their utilization can be beneficial, examines their constraints when considering routine clinical application, and discuss future development.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135605689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prognostic models and autoimmune liver diseases 预后模型与自身免疫性肝病

IF 3.2 3区医学

Best Practice & Research Clinical Gastroenterology Pub Date : 2023-12-01 DOI: 10.1016/j.bpg.2023.101878

Daphne D'Amato , Marco Carbone

{"title":"Prognostic models and autoimmune liver diseases","authors":"Daphne D'Amato , Marco Carbone","doi":"10.1016/j.bpg.2023.101878","DOIUrl":"10.1016/j.bpg.2023.101878","url":null,"abstract":"<div><p>Autoimmune liver diseases (AILDs) are complex diseases with unknown causes and immune-mediated pathophysiology. In primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH) disease modifying drugs are available which improve patient quality and quantity of life. In primary sclerosing cholangitis (PSC) no medical therapy is available and the only accepted treatment is liver transplantation (LT). PBC, PSC and AIH possess features that describe the archetype of patients within each disorder. On the other hand, the classical disorders are not homogeneous, and patients within each diagnosis may present with a range of clinical, biochemical, serological, and histological findings.</p><p>Singularly, they are considered rare diseases, but together, they account for approximately 20% of LTs in Europe and USA. Management of these patients is complex, as AILDs are relatively uncommon in clinical practice with challenges in developing expertise, disease presentation can be sneaky, clinical phenotypes and disease course are heterogeneous. Prognostic models are key tools for clinicians to assess patients’ risk and to provide personalized care to patients. Aim of this review is to discuss challenges of the management of AILDs and how the available prognostic models can help. We will discuss the prognostic models developed in AILDs, with a special focus on the prognostic models that can support the clinical management of patients with AILDs: in <span>PBC</span> models based on ursodeoxycholic acid (UDCA) response and markers of liver fibrosis; in PSC several markers including biochemistry, disease stage and radiological semiquantitative markers; and finally in AIH, markers of disease stage and disease activity.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1521691823000641/pdfft?md5=2d598001693700e286242f434e48bd93&pid=1-s2.0-S1521691823000641-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138506254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prognostic modelling in IBD IBD的预后模型

IF 3.2 3区医学

Best Practice & Research Clinical Gastroenterology Pub Date : 2023-12-01 DOI: 10.1016/j.bpg.2023.101877

Peter Rimmer , Tariq Iqbal

引用次数: 0

Prognostic models in alcohol-related liver disease and alcohol-related hepatitis 酒精相关肝病和酒精相关肝炎的预后模型

IF 3.2 3区医学

Best Practice & Research Clinical Gastroenterology Pub Date : 2023-12-01 DOI: 10.1016/j.bpg.2023.101867

Jessica Ann Musto, Michael Ronan Lucey

引用次数: 0